Bevacizumab in Colorectal Cancer: Current Role in Treatment and the Potential of Biosimilars
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1776-260X
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Bevacizumab in Colorectal Cancer: Current Role in Treatment and the Potential of Biosimilars ; volume:12 ; number:5 ; day:11 ; month:8 ; year:2017 ; pages:599-610 ; date:10.2017
Targeted oncology ; 12, Heft 5 (11.8.2017), 599-610, 10.2017
- Keyword
-
Krebs
Onkologie
- Creator
-
Rosen, Lee S.
- Contributor
-
Jacobs, Ira A.
Burkes, Ronald L.
SpringerLink (Online service)
- DOI
-
10.1007/s11523-017-0518-1
- URN
-
urn:nbn:de:1111-201711213917
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:36 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Rosen, Lee S.
- Jacobs, Ira A.
- Burkes, Ronald L.
- SpringerLink (Online service)
Other Objects (12)
Current perspectives on biosimilars
Biosimilars – Biosimilars: ja, aber
Will bevacizumab biosimilars impact the value of systemic therapy in gynecologic cancers?
Biosimilars
Biosimilars : Handbuch
Biosimilars : ein Handbuch
Biosimilars – Alternative wirkt
Biosimilars im Fokus : Diskussionspapier zur Substitution von Biosimilars in Apotheken
Biosimilars in hematology and oncology
PANLAR consensus statement on biosimilars
Current colorectal cancer reports
Biologicals und Biosimilars in der Nephrologie
Current perspectives on biosimilars
Biosimilars – Biosimilars: ja, aber
Will bevacizumab biosimilars impact the value of systemic therapy in gynecologic cancers?
Biosimilars
Biosimilars : Handbuch
Biosimilars : ein Handbuch
Biosimilars – Alternative wirkt
Biosimilars im Fokus : Diskussionspapier zur Substitution von Biosimilars in Apotheken
Biosimilars in hematology and oncology
PANLAR consensus statement on biosimilars
Current colorectal cancer reports
Biologicals und Biosimilars in der Nephrologie
Current perspectives on biosimilars
Biosimilars – Biosimilars: ja, aber
Will bevacizumab biosimilars impact the value of systemic therapy in gynecologic cancers?
Biosimilars
Biosimilars : Handbuch
Biosimilars : ein Handbuch
Biosimilars – Alternative wirkt
Biosimilars im Fokus : Diskussionspapier zur Substitution von Biosimilars in Apotheken
Biosimilars in hematology and oncology
PANLAR consensus statement on biosimilars
Current colorectal cancer reports